-       Report 
   - August 2025
    -  192 Pages 
    Global
   
   From       €3181EUR$3,545USD£2,792GBP 
      €3535EUR$3,939USD£3,102GBP 
                -       Report 
   - January 2025
    -  175 Pages 
    Global
   
   From       €4029EUR$4,490USD£3,536GBP 
                -       Report 
   - July 2025
    -  350 Pages 
    Global
   
   From       €4441EUR$4,949USD£3,898GBP 
                -       Report 
   - March 2024
    -  192 Pages 
    Global
   
        €4482EUR$4,995USD£3,934GBP 
                -       Report 
   - May 2023
    -  83 Pages 
    Global
   
   From       €3500EUR$4,178USD£3,179GBP 
                       -       Book 
   - December 2015
    -  4176 Pages 
    
                     Nocturia is a condition in which a person wakes up multiple times during the night to urinate. It is a common symptom of both urological and nephrological disorders, such as benign prostatic hyperplasia, overactive bladder, and chronic kidney disease. Nocturia can also be caused by lifestyle factors, such as drinking too much fluid before bedtime or taking certain medications. Treatment options for nocturia include lifestyle modifications, medications, and medical devices.
The nocturia market is    composed of a variety of companies that offer products and services to diagnose and treat the condition. These include pharmaceutical companies that develop medications to treat nocturia, medical device companies that produce devices to help manage the condition, and diagnostic companies that provide tests to identify the underlying cause. Examples of companies in the nocturia market include Allergan, Astellas Pharma, and Cogentix Medical. Show Less   Read more